標(biāo)題: Titlebook: Recombinant Antibodies for Cancer Therapy; Methods and Protocol Martin Welschof,Jürgen Krauss Book 2003 Humana Press 2003 [打印本頁(yè)] 作者: 從未迷惑 時(shí)間: 2025-3-21 19:34
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy影響因子(影響力)
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy被引頻次
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy被引頻次學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy年度引用
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy年度引用學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy讀者反饋
書(shū)目名稱(chēng)Recombinant Antibodies for Cancer Therapy讀者反饋學(xué)科排名
作者: cancer 時(shí)間: 2025-3-21 23:49
Generation of Antibody Molecules Through Antibody Engineeringances in the fields of cell biology and clinical diagnostics (.). However, in spite of their early promise, monoclonal antibodies (MAbs) were largely unsuccessful as therapeutic reagents resulting from insufficient activation of human effector functions and immune reactions against proteins of murin作者: Commodious 時(shí)間: 2025-3-22 02:20
Application of Recombinant Antibodies in Cancer Patientsnical trials since the early 1980s. Clinical outcomes were generally poor (.–.), with the notable exception of marked tumor responses, including long-term remissions of patients with malignant B-cell lymphoma who were treated with patient-specific antiidiotypic antibodies (.–.). The main factors res作者: Pulmonary-Veins 時(shí)間: 2025-3-22 06:52
DNA Immunization as a Means to Generate Antibodies to Proteins for a number of intractable diseases. Their uses include identification and cloning of new genes from expression libraries, purification and structure-function analysis of proteins, histochemical localization of proteins, as diagnostic markers and/or probes, as targeting agents to deliver drugs and作者: 無(wú)孔 時(shí)間: 2025-3-22 09:48 作者: 人類(lèi)的發(fā)源 時(shí)間: 2025-3-22 15:36 作者: ICLE 時(shí)間: 2025-3-22 20:03 作者: 幻影 時(shí)間: 2025-3-22 23:46
Single-Domain VH Antibody Fragments from a Phage Display Libraryng any given molecular entity (antigen). Antigen recognition is conferred to the antibody by a limited number of hypervariable surface loops, differing in sequence and in length, which are connected to a conserved framework structure.作者: Customary 時(shí)間: 2025-3-23 04:57
Isolation of Human Fab Fragments Against Ovarian Carcinoma Using Guided Selectionchemotherapeutic agents for the treatment of ovarian cancer, survival is still poor. Major problems in ovarian cancer chemotherapies are a failure to consolidate response, acquired/intrinsic drug resistance, and dose-limiting toxicity. Thus new therapeutic treatment modalities have been developed, m作者: cornucopia 時(shí)間: 2025-3-23 06:27 作者: 樹(shù)木中 時(shí)間: 2025-3-23 11:16 作者: 鉗子 時(shí)間: 2025-3-23 14:14 作者: 裹住 時(shí)間: 2025-3-23 21:33
Tailoring Kinetics of Antibodies Using Focused Combinatorial Librariesles to produce agonist, antagonist, or neutralizing activity. Antibody therapies have been applied successfully in the treatment of several human diseases (.). The advantages of antibodies over other molecules are that they have high affinity for their targets and they bind to targets with high spec作者: opportune 時(shí)間: 2025-3-23 23:45 作者: Bricklayer 時(shí)間: 2025-3-24 03:45 作者: 擴(kuò)音器 時(shí)間: 2025-3-24 08:42 作者: 忘恩負(fù)義的人 時(shí)間: 2025-3-24 14:33 作者: Amenable 時(shí)間: 2025-3-24 17:59 作者: 詞匯表 時(shí)間: 2025-3-24 22:15 作者: Nucleate 時(shí)間: 2025-3-25 02:57
Generation of Antibody Molecules Through Antibody Engineeringtely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule (.), where functional domains carrying antigen-binding activities (Fabs or Fvs) or effector functions (Fc) can be exchanged between antibodies (..).作者: 脫毛 時(shí)間: 2025-3-25 06:37 作者: 窩轉(zhuǎn)脊椎動(dòng)物 時(shí)間: 2025-3-25 08:47 作者: 使隔離 時(shí)間: 2025-3-25 12:30
Tailoring Kinetics of Antibodies Using Focused Combinatorial Librariesof binding virtually any molecule including proteins, carbohydrates, nucleic acids, and haptens. The intrinsic features of specificity and affinity when combined offer a great advantage in the discovery of a wide-range of lead drug candidates.作者: 高貴領(lǐng)導(dǎo) 時(shí)間: 2025-3-25 16:32
Humanization of Monoclonal Antibodies by CDR GraftingThe discovery of the process for making rodent monoclonal antibodies (MAbs) 26 years ago by Kohler and Milstein has led to a revolution in the treatment of over 50 major diseases, and has borne an industry whose products today represent 6% of total biotechnology sales. The full potential of this industry has still to be reached.作者: 和平 時(shí)間: 2025-3-25 23:01
Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer TherapyThe rapid progress in understanding the molecular biology of cancer cells has made a large impact on the design and development of novel therapeutic strategies.作者: Amnesty 時(shí)間: 2025-3-26 03:06 作者: 使迷惑 時(shí)間: 2025-3-26 05:05 作者: Aggregate 時(shí)間: 2025-3-26 09:04
Recombinant Antibodies for Cancer Therapy978-1-59259-334-7Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Detonate 時(shí)間: 2025-3-26 14:23
Single-Domain VH Antibody Fragments from a Phage Display Libraryng any given molecular entity (antigen). Antigen recognition is conferred to the antibody by a limited number of hypervariable surface loops, differing in sequence and in length, which are connected to a conserved framework structure.作者: 改革運(yùn)動(dòng) 時(shí)間: 2025-3-26 18:32
1064-3745 s step-by-step. Moreover, each protocol supplies a troubleshooting guide containing detailed information on possible problems and hints for pot- tial solutions. Antibody technology is a subject978-1-61737-250-6978-1-59259-334-7Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: 采納 時(shí)間: 2025-3-26 21:52
Martin Welschof,Christiane Christ,Ingrid Hermes,Armin Keller,Christian Kleist,Michael Braunagel作者: 混合,攙雜 時(shí)間: 2025-3-27 01:56
Mariangela Figini,Andrew Green,Francesco Colotta,Silvana Canevari作者: 失望昨天 時(shí)間: 2025-3-27 07:40
Chimerization of a Monoclonal Antibody for Treating Hodgkin’s Lymphomain Saporin to treat four patients with refractory Hodgkin’s lymphoma (.). However, despite remarkable tumor reductions of up to more than 75% were achieved after administration of one single dose of the reagent, patients developed an immune response against both the rodent immunoglobulin and the tox作者: Pcos971 時(shí)間: 2025-3-27 13:26 作者: 走路左晃右晃 時(shí)間: 2025-3-27 14:30
Engineering Hot Spots for Affinity Enhancement of Antibodiesfferent approaches to improve binding affinity of antibodies (whole IgGs, Fabs, and Fvs). One approach relied on the high-resolution crystal structure of antibody-antigen complex followed by engineering of key contact residues in the Fv portion to enhance the interaction. Although this approach is v作者: cancellous-bone 時(shí)間: 2025-3-27 20:07 作者: 繁榮中國(guó) 時(shí)間: 2025-3-27 23:51 作者: 護(hù)身符 時(shí)間: 2025-3-28 04:45
Partha S. Chowdhuryrochen: 1. Die Simultanproduktion des gleichen Textes (Sprechchor), 2. die lineare und Laufzeitverzerrung im übertragungsweg durch Iteration und 3. die Einführung von additiven St?rungen (Ger?uschen) in den übertragungsweg. Mit Hilfe der verz?gerten Schallrückkopplung vom Mund zum Ohr des sprechende作者: ensemble 時(shí)間: 2025-3-28 08:59
Jürgen Krauss,Hans Heinrich F?rster,Barbara Uchanska-Ziegler,Andreas Zieglerrochen: 1. Die Simultanproduktion des gleichen Textes (Sprechchor), 2. die lineare und Laufzeitverzerrung im übertragungsweg durch Iteration und 3. die Einführung von additiven St?rungen (Ger?uschen) in den übertragungsweg. Mit Hilfe der verz?gerten Schallrückkopplung vom Mund zum Ohr des sprechende作者: Inexorable 時(shí)間: 2025-3-28 10:36
Siobhan O’Brien,Tarran Jonesrochen: 1. Die Simultanproduktion des gleichen Textes (Sprechchor), 2. die lineare und Laufzeitverzerrung im übertragungsweg durch Iteration und 3. die Einführung von additiven St?rungen (Ger?uschen) in den übertragungsweg. Mit Hilfe der verz?gerten Schallrückkopplung vom Mund zum Ohr des sprechende作者: palpitate 時(shí)間: 2025-3-28 15:15
Jan Engberg,Ali F. Yenidunya,Rikke Clausen,Liselotte B. Jensen,Peter S?rensen,Pernille Kops,Erik Rii Mischphase gegebenen atomaren Aufbau eine wesentliche Rolle. Die Analyse dieser Faktoren ist bei der Betrachtung eines zuf?llig herausgegriffenen bin?ren Systems oft recht problematisch. Es gibt indessen F?lle, in denen einer dieser Einflüsse dominiert und dadurch leicht quantitativen Betrachtungen作者: ARCH 時(shí)間: 2025-3-28 19:23 作者: 終點(diǎn) 時(shí)間: 2025-3-28 23:36 作者: 樹(shù)膠 時(shí)間: 2025-3-29 06:09 作者: Cognizance 時(shí)間: 2025-3-29 09:28 作者: cogent 時(shí)間: 2025-3-29 12:51 作者: 概觀(guān) 時(shí)間: 2025-3-29 16:15 作者: 預(yù)兆好 時(shí)間: 2025-3-29 22:26
Jan Engberg,Ali F. Yenidunya,Rikke Clausen,Liselotte B. Jensen,Peter S?rensen,Pernille Kops,Erik Riitlich angedeutet, kommt die Vielfalt der von System zu System oft sehr unter-schiedlichen energetischen Verh?ltnisse und die damit zusammenh?ngende Mannigfaltigkeit der in den Zustandsdiagrammen zusammengefa?ten Phasengleichgewichte durch das Zusammenspiel mehrerer Einflu?gr??en zustande. Es sind di作者: Ingenuity 時(shí)間: 2025-3-30 03:25
Partha S. Chowdhurytlich angedeutet, kommt die Vielfalt der von System zu System oft sehr unter-schiedlichen energetischen Verh?ltnisse und die damit zusammenh?ngende Mannigfaltigkeit der in den Zustandsdiagrammen zusammengefa?ten Phasengleichgewichte durch das Zusammenspiel mehrerer Einflu?gr??en zustande. Es sind di作者: 樹(shù)上結(jié)蜜糖 時(shí)間: 2025-3-30 07:02
Partha S. Chowdhury,George Vasmatzisich von der Wasserführung des Flusses ab. Es kann hier die H?henlage des Oberwassers nicht willkürlich geregelt werden. Bei Flüssen mit starken Hochw?ssern und Eisgang wird zu gewissen Zeiten ein hoher Stau eintreten, der den Uferanwohnern nachteilig und gef?hrlich werden kann. Die Hochw?sser k?nnen作者: 剝皮 時(shí)間: 2025-3-30 11:21 作者: incredulity 時(shí)間: 2025-3-30 14:36
Modeling Flu Trends with Real-Time Geo-tagged Twitter Data Streams,ults with official statistics from Center for Disease Control and Prevention (CDC). Our preliminary results have demonstrated that real-time tweet streams capture the dynamics of influenza at national level, and could potentially serve as an early warning system of influenza epidemics or flu trends.作者: 空中 時(shí)間: 2025-3-30 19:55
https://doi.org/10.1007/978-3-662-05584-7arative approach, across organisms, regions, and ecosystems. GEOHAB advanced our understanding of the mechanisms underlying population dynamics of HABs within an ecological and oceanographic context and also from the ecosystem perspective at the regional scale. GEOHAB encouraged combined experimenta作者: PHIL 時(shí)間: 2025-3-30 23:52 作者: 殘酷的地方 時(shí)間: 2025-3-31 01:07
Imaging and Manipulation of Molecular Electronic States on Metal Surfaces with Scanning Tunneling Mie bond is permanently either formed or broken, the bonding state continuously oscillates at higher voltages. The switching rate of the bistable molecular system can be widely tuned from below 1?Hz up to the kilohertz regime. The quantum yield per tunneling electron to trigger a transition between th作者: 糾纏 時(shí)間: 2025-3-31 08:25
2211-8136 some pragmatic and semiotic values of the technology used? These are some of the concerns addressed in the book by expert scholars in this area of research in mathematics education. This volume is the first de978-3-319-82820-6978-3-319-43423-0Series ISSN 2211-8136 Series E-ISSN 2211-8144 作者: Ledger 時(shí)間: 2025-3-31 09:25 作者: languid 時(shí)間: 2025-3-31 15:16 作者: 個(gè)阿姨勾引你 時(shí)間: 2025-3-31 19:40
Berliner Schriften zur Museumskundehttp://image.papertrans.cn/n/image/641469.jpg
